TSO

TriSourceObserve

Slow journalism for technology, industry, and capital.

Stories

Capital Flow

Shows how policy, balance sheets, market structure, and investor expectations transmit change across industries.

AllMacro InsightsCorporate StrategyFinTech & Future AssetsSector Deep-dive
TSO / High confidence
Capital FlowCorporate Strategy

Shareholder Backlash at BP’s Annual General Meeting: Manifold’s Re-election Stumbles as Climate Resolution Dispute Intensifies

BP faced a shareholder backlash at its 2026 annual general meeting. All three sources confirm that Chairman Albert Manifold faced a notable protest vote and that the company did not receive the expected support for some proposals; one source also says the dispute centered on BP’s blocking of a climate resolution from Follow This. The exact names of the defeated proposals, the precise protest-vote percentage, and the details of the governance dispute were not fully consistent across the sources provided.

Apr 30, 2026
Read analysis
TSO / High confidence
Capital FlowMacro Insights

Bank of Japan Holds Rates Steady and Lifts Inflation Forecast Amid Iran War-Driven Energy Price Concerns

On April 28, 2026, the Bank of Japan kept its policy rate unchanged and raised its inflation forecast amid concerns that the Iran war could push up energy prices; the decision passed by a 6-3 vote. The provided sources confirm that Japan’s March inflation remained below the BOJ’s 2% target, though they are not fully consistent on the exact measures and month-on-month comparisons, and some details cannot be verified from the available sources.

Apr 30, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Tortugas Neuroscience completes $106 million seed and Series A financing, with Cure Ventures leading

Framingham-based Tortugas Neuroscience announced a $106 million seed and Series A financing led by Cure Ventures, with The Column Group and AN Venture Partners participating. Source alignment confirms the funding amount, lead investor, and participating firms; however, details on the use of proceeds, the scope of the candidate drugs, and the company’s background are not fully consistent across sources, and some information cannot be verified from the provided materials.

Apr 29, 2026
Read analysis
TSO / High confidence
Capital FlowCorporate Strategy

China Halts Meta’s Acquisition of AI Startup Manus: Foreign Investment Security Review Raises Cross-Border M&A Compliance Concerns

According to reports, China’s National Development and Reform Commission, acting under the foreign investment security review mechanism, ordered the cancellation and blocking of Meta’s acquisition of AI startup Manus. All three sources confirm that the deal was stopped by Chinese authorities, but they differ on whether Meta was explicitly named, whether the transaction had already been completed, and other background details; some information cannot be confirmed from the provided sources.

Apr 29, 2026
Read analysis
TSO / High confidence
Capital FlowMacro Insights

ECB and Nexo Standards, Berlin Group, and ECPC Reach Digital Euro Standards Cooperation Agreement

The European Central Bank (ECB) has reached a new agreement with Nexo Standards, Berlin Group, and the European Cards Payment Cooperation (ECPC) to base digital euro online payments on existing open technical standards. All three sources confirm this core fact, but provide no verifiable details on offline payments, ISO 20022, alias initiation, balance checks, CPACE contact payments, or the project timeline; such information cannot be confirmed from the given sources.

Apr 29, 2026
Read analysis
TSO / High confidence
Capital FlowSector Deep-dive

Omdia Raises 2026 Semiconductor Revenue Growth Forecast to 62.7% as AI Lifts Memory Chip Demand

Omdia has raised its forecast for global semiconductor revenue growth in 2026 to 62.7%. The sources consistently point to AI-driven surging demand for DRAM and NAND, along with ongoing supply shortages. A third-party report citing TrendForce says memory prices will still rise sharply in Q2 2026 and that HBM prioritization is squeezing supply for other end markets. The claim that shortages will continue into 2027 is not directly confirmed by Sources 1 and 2, while Source 3 reflects a different institution’s longer-term supply-demand outlook and cannot be equated with Omdia’s conclusion.

Apr 26, 2026
Read analysis